What’s new

• Adline Chem Lab had zero revenue from operations for both Q4 and FY26.
• Net loss of ₹9.26 lakhs for the quarter and ₹28.11 lakhs for the full year.
• Accumulated losses of ₹7.62 cr exceed paid-up capital of ₹5.85 cr, creating negative equity.

Why it matters

Zero revenue means the company has no commercial operations to report. The negative equity is the more serious issue; it means the company's liabilities exceed its assets, a classic indicator of insolvency risk. This is a balance sheet in distress.

What we’re watching

• Whether the company has a plan to reverse negative equity or raise new capital.
• If any promoter action or board moves signal a change in strategy.
• Any potential regulatory scrutiny given the prolonged zero-revenue status.

The full read

Adline Chem Lab is a company with no revenue. Its audited results for FY26 confirm zero income from operations for both the final quarter and the full year. The net losses, ₹9.26 lakhs for Q4 and ₹28.11 lakhs for the year, are modest in absolute terms, but they are the wrong direction for a firm already deep in the red. The real number is the balance sheet. Accumulated losses stand at ₹7.62 crore, which exceeds the entire paid-up capital of ₹5.85 crore. Net worth is not just zero; it is negative. The company is technically insolvent on an equity basis. Without new capital or a viable commercial plan, this financial position is unsustainable.

Primary source: BSE · NSE